(photo by Susan Urmy)
Carlos Arteaga, M.D., (right) director of the Vanderbilt-Ingram Breast Cancer Program, chats with Dennis Slamon, M.D., Ph.D., co-developer of the breast cancer drug Herceptin, during the annual Vanderbilt-Ingram Cancer Center retreat May 4 at the Vanderbilt Student Life Center. Slamon, chief of Hematology/Oncology at the University of California, Los Angeles, gave the keynote address at the retreat, which focused on advances in breast cancer research.